{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T20:32:17Z","timestamp":1720816337886},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00108-019-00691-1","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T12:06:58Z","timestamp":1572955618000},"page":"357-361","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medikament\u00f6se Therapie der Herzinsuffizienz bei Niereninsuffizienz"],"prefix":"10.1007","volume":"61","author":[{"given":"Nikolaus","family":"Marx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"691_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"Anonymous","year":"1999","unstructured":"Anonymous (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a\u00a0randomised trial. Lancet 353:9\u201313","journal-title":"Lancet"},{"key":"691_CR2","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"Anonymous","year":"1999","unstructured":"Anonymous (1999) Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001\u20132007","journal-title":"Lancet"},{"key":"691_CR3","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jacc.2011.04.041","volume":"58","author":"SV Badve","year":"2011","unstructured":"Badve\u00a0SV, Roberts\u00a0MA, Hawley\u00a0CM et al (2011) Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a\u00a0systematic review and meta-analysis. J\u00a0Am Coll Cardiol 58:1152\u20131161","journal-title":"J Am Coll Cardiol"},{"key":"691_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1053\/j.ajkd.2017.12.006","volume":"72","author":"AA House","year":"2018","unstructured":"House\u00a0AA (2018) Management of heart failure in advancing CKD: core curriculum 2018. Am J Kidney Dis 72:284\u2013295","journal-title":"Am J Kidney Dis"},{"key":"691_CR5","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ Mcmurray","year":"2014","unstructured":"Mcmurray\u00a0JJ, Packer\u00a0M, Desai\u00a0AS et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N\u00a0Engl J Med 371:993\u20131004","journal-title":"N Engl J Med"},{"key":"691_CR6","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer\u00a0M, Bristow\u00a0MR, Cohn\u00a0JN et\u00a0al (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N\u00a0Engl J Med 334:1349\u20131355","journal-title":"N Engl J Med"},{"key":"691_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski\u00a0P, Voors\u00a0AA, Anker\u00a0SD et\u00a0al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891\u2013975","journal-title":"Eur J Heart Fail"},{"key":"691_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad\u00a0F, Mcmurray\u00a0JJ, Krum\u00a0H et\u00a0al (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N\u00a0Engl J Med 364:11\u201321","journal-title":"N Engl J Med"},{"key":"691_CR9","doi-asserted-by":"crossref","unstructured":"(2013) Summary of recommendation statements. Kidney Int Suppl (2011) 3(3):263\u2013265","DOI":"10.1038\/kisup.2013.31"},{"key":"691_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11897-018-0406-8","volume":"15","author":"M Arrigo","year":"2018","unstructured":"Arrigo\u00a0M, Cipp\u00e0\u00a0PE, Mebazaa\u00a0A (2018) Cardiorenal interactions revisited: how to improve heart failure outcomes in patients with chronic kidney disease. Curr Heart Fail Rep 15:307\u2013314","journal-title":"Curr Heart Fail Rep"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-00691-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-00691-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-00691-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:46:52Z","timestamp":1603932412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-00691-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["691"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-00691-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"30 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"N.\u00a0Marx erh\u00e4lt Forschungsunterst\u00fctzung zu diesem Thema von der Deutschen Forschungsgemeinschaft (DFG, TTR 219, M\u201103, M\u201105).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}